LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer

Cancer Research

Volumn 68, Issue 17, 2008, Pages 7147-7155

  Kim, Mirang ^a,b   Kim, Jeong Hwan ^a   Jang, Hay Ran ^a   Kim, Hwan Mook ^a   Lee, Chang Woo ^a   Noh, Seung Moo ^a   Song, Kyu Sang ^a   Cho, June Sik ^a   Jeong, Hyun Yong ^a   Hahn, Yoonsoo ^c   Yeom, Young Il ^a   Yoo, Hyang Sook ^a   Yong, Sung Kim ^a,b,d  

^a Chungnam National University   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Chung Ang University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; INTERFERON; LEUCINE RICH REPEAT CONTAINING PROTEIN 3B; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; AZACITIDINE; DRUG DERIVATIVE; HISTONE; HYDROXAMIC ACID; LRRC3B PROTEIN, HUMAN; PRIMER DNA; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; ACETYLATION; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SOUTHERN BLOTTING; STOMACH TUMOR; TUMOR CELL LINE;

ACETYLATION; ANIMALS; AZACITIDINE; BASE SEQUENCE; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA PRIMERS; DOWN-REGULATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 52049115152     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0667     Document Type: Article

References (46)

1. Clark HF, Gurney AL, Abaya E, et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 2003;13:2265-70.
2. Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995;374:183-6.
3. Kajava AV, Kobe B. Assessment of the ability to model proteins with leucine-rich repeats in light of the latest structural information. Protein Sci 2002;11:1082-90.
4. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001;11:725-32.
5. Kajava AV. Structural diversity of leucine-rich repeat proteins. J Mol Biol 1998;277:519-27.
6. Pancer Z, Cooper MD. The evolution of adaptive immunity. Annu Rev Immunol 2006;24:497-518.
7. Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003;14:3208-15.
8. Richardson AL, Wang ZC, De Nicolo A, et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006;9:121-32.
9. Bianchini M, Levy E, Zucchini C, et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol 2006;29:83-94.
10. Korkola JE, Houldsworth J, Chadalavada RS, et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006;66:820-7.
11. Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004;101:811-6.
12. Sun L, Hui AM, Su Q, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006;9:287-300.
13. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
14. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-16.
15. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
16. Kim JH, Lee KT, Kim HC, et al. Cloning of NotI-linked DNA detected by restriction landmark genomic scanning of human genome. Genomics & Informatics 2006;4:1-10.
17. Kim SK, Jang HR, Kim JH, et al. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Biochem Biophys Res Commun 2006;349:1032-40.
18. Kim M, Lee KT, Jang HR, et al. Epigenetic downregulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. Mol Cancer Res 2008;6:222-30.
19. Kim M, Jang HR, Kim JH, et al. . Ep gienetic inactivation of Protein Kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis 2008;29:629-37.
20. Park JG, Frucht H, LaRocca RV, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res 1990;50:2773-80.
21. Park JG, Yang HK, Kim WH, et al. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 1997;70:443-9.
22. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci U S A 1991;88:9523-7.
23. Nagai H, Tsumura H, Ponglikitmongkol M, Kim YS, Matsubara K. Genomic aberrations in human hepatoblastomas detected by 2-dimensional gel analysis. Cancer Res 1995;55:4549-51.
24. Nagai H, Pongliktmongkol M, Kim YS, Yoshikawa H, Matsubara K. Cloning of NotI-cleaved genomic DNA fragments appearing as spots in 2D gel electrophoresis. Biochem Biophys Res Commun 1995;213:258-65.
25. Nagai H, Ponglikitmongkol M, Mita E, et al. Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 1994;54:1545-50.
26. Johnson MR, Wang K, Smith JB, Heslin MJ, Diasio RB. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem 2000;278:175-84.
27. Han DC, Lee MY, Shin KD, et al. 2′-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem 2004;279:6911-20.
28. Kim SY, Kim JH, Lee HS, et al. Meta- and gene set analysis of stomach cancer gene expression data. Mol Cells 2007;24:200-9.
29. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
30. Kim JM, Sohn HY, Yoon SY, et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 2005;11:473-82.
31. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007;8:286-98.
32. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980;20:85-93.
33. Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-9.
34. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007;121:1-14.
35. Maleckar JR, Sherman LA. The composition of the T cell receptor repertoire in nude mice. J Immunol 1987;138:3873-6.
36. Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA, Powell SM. Allelotype of gastric adenocarcinoma. Cancer Res 1999;59:1437-41.
37. Choi SW, Park SW, Lee KY, Kim KM, Chung YJ, Rhyu MG. Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene 1998;17:2655-9.
38. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
39. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
40. Stull RA, Tavassoli R, Kennedy S, et al. Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors. BMC Genomics 2005;6:55.
41. Creighton C, Kuick R, Misek DE, et al. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol 2003;4:R46.
42. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002;3:999-1005.
43. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, Tainsky MA. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003;22:4118-27.
44. Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
45. Harada H, Kitagawa M, Tanaka N, et al. Antioncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-4.
46. Andrews HN, Mullan PB, McWilliams S, et al. BRCA1 regulates the interferon g-mediated apoptotic response. J Biol Chem 2002;277:26225-32.